High Power Short Duration Ablation Compared to Moderate Power Long Duration Ablation for Pulmonary Vein Isolation

Completed

• Conditions: Paroxysmal Atrial Fibrillation

• Registration Number: NCT05959798
• Lead Sponsor: Deutsches Herzzentrum Muenchen

Brief Summary

High Power Short Duration Ablation Compared to Moderate Power Long Duration Ablation for Pulmonary Vein Isolation: safety and acute procedural outcome

Detailed Description

Not available

Study Timeline

• Study Start: 2019-04-20
• Status Verified: 2023-07
• Primary Completion: 2023-07-17
• Study Completion: 2023-07-17
• Study First Submitted: 2023-07-17
• Study First Submitted QC: 2023-07-17
• Last Update Submitted: 2023-07-17
• Study First Posted: 2023-07-25
• Last Update Posted: 2023-07-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 204

Inclusion Criteria

• symptomatic, documented, drug-resistent paroxysmal atrial fibrillation
• effective oral anticoagulation

Exclusion Criteria

• any prior left atrial ablation procedure
• presence of left atrial thrombus
• secondary atrial fibrillation due to electrolyte imbalance or thyroid disease
• any prior oesophageal or gastric surgery

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of reconnected pulmonary veins 20 minutes after ablation in comparison of both ablation groups	Acute endpoint

Secondary Outcome Measures

Name	Time	Method
Time to first documented recurrence of atrial fibrillation after a 6-week blanking period.	12 months after ablation

Trial Locations

Locations (1)

Deutsches Herzzentrum München; 🇩🇪 München, Germany